Creating #preciselytargetedtherapies for patients with cancer, designed to overcome limitations of existing therapies for clinically proven kinase targets
Cambridge, MA
Joined January 2021
- Tweets328
- Following91
- Followers624
- Likes16
Today, Nuvalent officially becomes part of GSK. Building on our legacy of strong science and commitment to patients, we look forward to continuing to advance innovative, precisely targeted medicines for people living with cancer, together. Learn more: gsk.to/3T1uzts
Oncology care is a coordinated effort built on expertise, communication, and trust, with patients and clinicians partnering in informed decision-making.
Gail’s advice reminds us of the importance of leaning on your care team for support as you navigate your treatment journey.
Knowledge is power when facing a #LungCancer diagnosis. Did you know that broader awareness of NSCLC subtypes and #EarlyDetection through biomarker testing are critical to more informed care? Find FAQs on ROS1+ or ALK+ NSCLC here on: elevatelungcancercare.com.
This year’s 20th Annual Bio-Ball tournament was a SLAM DUNK! 🏀🔥 Unforgettable moments with the @SpOlympicsMA athletes and the #NuCrew. We are proud to support an organization that promotes inclusion, empowerment, and the power of sport!
Advocacy can help drive meaningful change for patients with ALK+ #LungCancer.
Empower yourself and ensure your voice is heard with a tailored care plan. Explore our doctor discussion guide and other patient resources at elevatelungcancercare.com/AL…
Nuvalent retweeted
#News for #investors and #media:
We have entered an agreement to acquire clinical-stage precision oncology company Nuvalent, Inc., bringing in multiple lung cancer assets to our existing oncology portfolio.
Find out more: gsk.to/4ooHOjy
Today on #NationalCancerSurvivorsDay, we recognize the strength and resilience of all #CancerSurvivors, including those facing the unique challenges of ALK+ and ROS1+ #LungCancer.
To patients, caregivers, and loved ones: we stand with you.💪 #ALKPositive #ROS1Positive
Proud to stand with @ALKPositiveinc & the ALK #LungCancer community for #ALKAwarenessMonth!🎗️#FuelTheCure honors the patients, researchers & advocates driving progress. Together, we fuel hope, research & innovation. #APAM26
Additionally, we are pleased to welcome Georg Pirmin Meyer, M.D. as Chief International Officer to lead our international expansion strategy.
Learn more here: investors.nuvalent.com/2026-…
We recognize the emotional weight of a #LungCancer journey. This #MentalHealthAwareness month, find strength through support. Connect with patient advocacy groups like @ALKPositiveinc and @ros1cancer, where patients & caregivers come together to share and uplift one another.
This morning, we reported our Q1 2026 financial results, along with recent pipeline and business progress and anticipated milestones. Learn more here. investors.nuvalent.com/2026-…
During #CancerPrevention and #EarlyDetection Month, we’re honoring the stories of patients like Luna and Brandi. Through biomarker testing, they discovered important answers that helped guide their treatment journeys. Learn about ROS1 & ALK+ NSCLC & more→elevatelungcancercare.com.